Innovation and Biologics Demand in the US Plasma Fractionation Market

adicionou um novo artigo Health

2026-06-19 09:32:06 -

The United States represents the largest contributor to the plasma fractionation industry globally, supported by a well-established plasma collection infrastructure, advanced biopharmaceutical manufacturing capabilities, and a high adoption rate of plasma-derived therapies. The growing prevalence of primary immunodeficiency disorders, hemophilia, autoimmune diseases, and neurological conditions...

0 Comentários 0 Compartilhamentos 58 Visualizações 0 Anterior